INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2021

Resveratrol supplementation significantly lowered HOMA-IR in type 2 diabetes patients, without significant effects on total cholesterol or triglycerides.

A systematic review and meta-analysis evaluated 15 RCTs involving 896 patients with type 2 diabetes to assess the efficacy and safety of resveratrol supplements. Compared with controls, HOMA-IR was significantly lower in the resveratrol group (WMD: -0.99; 95% CI -1.61, -0.38; P=0.002). No statistically significant differences were observed for total cholesterol (WMD: -7.11; 95% CI -16.28, 2.06; P=0.13), triglycerides (WMD: -2.15; 95% CI -5.52, 1.22; P=0.21), or adverse events (WMD: 2; 95% CI 0.44, 9.03; P=0.37).

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
896 patients with type 2 diabetes across 15 RCTs
What was measured
Insulin-resistance-related indicators, blood lipids (TC, TG), and adverse events

THE PAPER

Efficacy and Safety of Resveratrol Supplements on Blood Lipid and Blood Glucose Control in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Zhang T, He Q, Liu Y, Chen Z, Hu H. Evid Based Complement Alternat Med, 2021.

PubMed 34484395 ↗DOI 10.1080/10408398.2017.1422480 ↗

Diabetes & blood sugar

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.